AWARD
A -- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for cGMP Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing
- Notice Date
- 9/16/2024 12:24:32 PM
- Notice Type
- Award Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- NIH NCI Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N91024D00008
- Archive Date
- 09/28/2024
- Point of Contact
- Megan Osele, Contracting Officer
- E-Mail Address
-
megan.osele@nih.gov
(megan.osele@nih.gov)
- Award Number
- 75N91024D00008
- Award Date
- 09/13/2024
- Awardee
- CURIA BIO INC Albany NY 12203 USA
- Award Amount
- 149995000.00
- Description
- This is an IDIQ award (with potential fixed-price and cost plus fixed fee task orders) associated with the CGMP Pool under the PREVENT Preclinical Drug Development Program awarded competitively.�
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/8f62eacf01814c149d890de2e0816392/view)
- Place of Performance
- Address: Belmont, CA 94002, USA
- Zip Code: 94002
- Country: USA
- Zip Code: 94002
- Record
- SN07211482-F 20240918/240916230106 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |